Comprehensive analysis of Baroda BNP Paribas Dividend Yield Fund - Reg (G) (45015) providing detailed insights into fund performance, portfolio holdings, risk metrics, expense ratios, and investment recommendations.
Baroda BNP Paribas Asset Management India Ltd
The investment objective is to provide medium to long term appreciation by predominantly investing in a well-diversified portfolio of equity and equity related instruments of dividend yielding companies. There is no assurance that the investment objective of the Scheme will be achieved.
A comprehensive at-a-glance view of key mutual fund health indicatorsHover or click any card to view detailed metrics
Good Returns
High Risk
High Expenses
Equity Focused
New Team
Below Average
Showing 1Y NAV history
Performance across different time periods
Fund shows concerning indicators. Exercise caution before investing.
Consider waiting for better market conditions or explore alternatives.
Fund shows concerning indicators. Exercise caution before investing.
Consider waiting for better market conditions or explore alternatives.
Recent performance momentum
Outperformance vs benchmark
Market exposure level
Risk-adjusted returns
Assets under management
Fund manager experience
Historical performance consistency
Fund management costs
This fund has outperformed its benchmark by 2.93% over the 3Y period.
See how your money can grow and compare with popular investment options
Disclaimer: Returns are illustrative and based on assumed rates. Mutual fund investments are subject to market risk. Please read scheme documents carefully.
| Company | Sector | % Assets |
|---|---|---|
| HDFC Bank Ltd | Banks | 6.30% |
| Reliance Industries Ltd | Refineries | 5.79% |
| Kotak Mahindra Bank Ltd | Banks | 5.15% |
| ICICI Bank Ltd | Banks | 4.63% |
| GE Vernova T&D India Ltd | Capital Goods - Electrical Equipment | 3.66% |
| Infosys Ltd | IT - Software | 2.83% |
| Larsen & Toubro Ltd | Infrastructure Developers & Operators | 2.46% |
| Hindustan Petroleum Corporation Ltd | Refineries | 2.18% |
| Glaxosmithkline Pharmaceuticals Ltd | Pharmaceuticals | 2.14% |
| Sun Pharmaceutical Industries Ltd | Pharmaceuticals | 2.13% |
Compare against Dividend Yield Fund category average
This comparison shows how the fund performs relative to the Dividend Yield Fund category average. Positive values indicate outperformance, while negative values show underperformance.
Compare with similar funds in Dividend Yield Fund category
| Fund Name | NAV | 1M | 3M | 6M |
|---|---|---|---|---|
| Aditya Birla SL Dividend Yield Fund - Direct (G) | ₹480.65 | 1.56% | 0.40% | 10.90% |
| Aditya Birla SL Dividend Yield Fund (G) | ₹437.20 | 1.48% | 0.19% | 10.45% |
| UTI-Dividend Yield Fund - Direct (G) | ₹189.83 | 1.36% | 2.26% | 13.41% |
| UTI-Dividend Yield Fund (G) | ₹175.75 | 1.31% | 2.11% | 13.07% |
| Franklin India Dividend Yield Fund - Direct (G) | ₹148.25 | 0.77% | -0.17% | 6.86% |
| Sundaram Dividend Yield Fund - Direct (G) | ₹145.65 | 1.04% | 1.07% | 12.35% |
| Franklin India Dividend Yield Fund (G) | ₹135.30 | 0.69% | -0.38% | 6.40% |
| Sundaram Dividend Yield Fund (G) | ₹133.26 | 0.93% | 0.76% | 11.67% |
| Sundaram Dividend Yield Fund - Direct (IDCW-H) | ₹64.97 | 1.04% | 1.07% | 12.31% |
| ICICI Pru Dividend Yield Equity Fund - Direct (G) | ₹58.45 | 1.83% | 3.12% | 15.12% |
A seasoned investment professional with over 1 years of experience in equity research and fund management. Known for consistent performance and a disciplined investment approach focused on quality growth stocks.